These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7922980)

  • 1. Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations.
    Harada Y; Katagiri T; Ito I; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y; Emi M
    Cancer; 1994 Oct; 74(8):2281-6. PubMed ID: 7922980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer.
    Ito I; Yoshimoto M; Iwase T; Watanabe S; Katagiri T; Harada Y; Kasumi F; Yasuda S; Mitomi T; Emi M
    Br J Cancer; 1995 Mar; 71(3):438-41. PubMed ID: 7880720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genetic alterations related to the development and progression of breast carcinoma.
    Nagayama K; Watatani M
    Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of high-risk breast cancer patients from genetic changes of their tumors.
    Watatani M; Inui H; Nagayama K; Imanishi Y; Nishimura K; Hashimoto Y; Yamauchi E; Hojo T; Kotsuma Y; Yamato M; Matsunami N; Yasutomi M
    Surg Today; 2000; 30(6):516-22. PubMed ID: 10883462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
    Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
    Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers.
    Nagahata T; Hirano A; Utada Y; Tsuchiya S; Takahashi K; Tada T; Makita M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Breast Cancer; 2002; 9(3):208-15. PubMed ID: 12185331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of genetic alterations and progression of primary breast cancer.
    Sato T; Akiyama F; Sakamoto G; Kasumi F; Nakamura Y
    Cancer Res; 1991 Nov; 51(21):5794-9. PubMed ID: 1682035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma.
    Tsukamoto K; Ito N; Yoshimoto M; Kasumi F; Akiyama F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 1998 Jan; 82(2):317-22. PubMed ID: 9445188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of gene alterations in intraductal breast neoplasms associated with histological type and grade.
    Tsuda H; Fukutomi T; Hirohashi S
    Clin Cancer Res; 1995 Mar; 1(3):261-7. PubMed ID: 9815981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis.
    Borg A; Zhang QX; Olsson H; Wenngren E
    Genes Chromosomes Cancer; 1992 Nov; 5(4):311-20. PubMed ID: 1283319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Loss of heterozygosity at different chromosomes in patients with breast cancer].
    Deng GR; He LW; Lin BY
    Zhonghua Yi Xue Za Zhi; 1994 Jan; 74(1):31-4, 63-4. PubMed ID: 7913405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of genetic alterations in sporadic breast tumors].
    Schmutzler RK; Homann A; Bierhoff E; Wiestler OD; von Daimling A; Krebs D
    Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():63-7. PubMed ID: 8672929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic markers as prognostic indicators in breast cancer.
    Wolman SR; Pauley RJ; Mohamed AN; Dawson PJ; Visscher DW; Sarkar FH
    Cancer; 1992 Sep; 70(6 Suppl):1765-74. PubMed ID: 1355402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome.
    Scheurlen WG; Schwabe GC; Joos S; Mollenhauer J; Sörensen N; Kühl J
    J Clin Oncol; 1998 Jul; 16(7):2478-85. PubMed ID: 9667267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between loss of heterozygosity at microsatellite loci and computerized nuclear morphometry in hepatocellular carcinoma.
    Suzuki K; Hirooka Y; Tsujitani S; Yamane Y; Ikeguchi M; Kaibara N
    Anticancer Res; 2000; 20(2B):1257-62. PubMed ID: 10810431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.